Investing In Psychedelic Company Stocks isn’t Binary It’s Multifaceted

 Did you know that the ‘shark’ investor, Mr. Kevin O’Leary was amongst the first businessperson to invest in psychedelic stocks? Initially, investors thought this investment to be a binary one. However, after the emergence of multiple start-ups that deal in research and preparation of authentic, FDA-approved psychoactive drugs, more capitalists joined stock market trading in psychedelic company stocks. One such player that entered the CSE in Feb’2021 is Bright Minds Biosciences (CSE: DRUG).

It is a biotechnology company that houses expert scientists, drug designers, and professionals focused on redesigning the psilocybin (active ingredient in Magic Mushrooms) molecules. Their molecular designs diminish hallucinating effect of psilocybin. Thus, it maximizes its impact on patients with brain health disorders, neuropathy, and neurological illnesses.

More Investors Seek To Trade-In Psychedelic Company Stocks


After Canada, cities in the USA and the UK are also voting for psychedelic therapy to be made legal. That’s w why, if you have a business in Canada, then this is the perfect time to fund a Bright Minds that is trading publicly on Canadian Stock Exchange.

Irrespective of the fact that most countries continue to include all psychedelic compounds as Schedule 1 drugs; capitalists, and businessmen are turning to new companies

Some reasons why investors are turning to psychedelic stocks are:


 


1. As per the latest studies, a wide range of mental health problems can possibly be cured by psychedelic compounds such as LSD, Magic Mushrooms, MDMA, and ketamine.

2. These active ingredients that occur naturally have the potential to cure patients with neurological problems who become unresponsive to SSRIs and opioids.

3. MDD, anxiety, PTSD, Bipolar disorder, Epilepsy, Chronic Pain, and even Parkinson’s are some brain health issues that psychedelic drugs can treat.

4. With the emergence of studies that prove what’s mentioned above, and since consumed Magic Mushrooms has been decriminalized in Canada, this is the perfect opportunity for investors to dive right into the trade of psychedelic company stocks.

5. Bright Minds Bio carries out exceptional research on psilocybin. They have been able to figure out how to maximize its therapeutical use.

6. All the above factors were why investors who backed psychedelic company stocks in 2020 got a whooping triple-digit return.

7. Many governments are also approving research on these drugs due to their ability to actually rewire the brain for better performance and productivity.

Final Words


Apart from all the above factors, the biggest one to keep in mind, if you doubt whether or not to invest in psychedelic stocks in Canada, is that more than 100 million mental health patients are already unresponsive to any sort of medication. Still, recent experiments prove that psychedelics have improved their brain health drastically.

That does not mean that one should just extract the psychoactive compound and commercialize it, coz there are many psychotic effects of these drugs.

Hence, the best company for psychedelic company stocks in Canada is Bright Minds Biosciences. The best part about this company is that they aren’t trying to commercialize psilocybin in general; they are trying to commercialize psychedelic therapy to provide their patented compounds to professionals who know how to administer the drugs for ones who need it.

Comments

Popular posts from this blog

Psychedelic Renaissance: The Resurgence of Psychedelic Research and Therapy

The Magic Mushrooms That Heal As Psychedelic Drugs

Understanding the Significance of Serotonin Levels in the Human Body